Back

Ecopha Biotech Signals Global Expansion with Australia-India Pongamia Bioeconomy Strategy

Ecopha Biotech

Key Facts:

• Ecopha Biotech announces strategic Australia-India partnership to commercialise their ecopha.bio technology™ for Pongamia-based bioeconomy
• Technology converts Pongamia oil into sustainable aviation fuel (SAF) and marine-biodegradable PHA bioplastics
• Single facility can process 1 million tonnes of oil annually, producing 700,000 tonnes of SAF and 200,000 tonnes of bioplastics
• Partnership leverages Australian technology innovation and Indian production/feedstock capacity
• Project aims to address aviation decarbonisation and plastic pollution while generating projected annual revenue of $3.2 billion

MELBOURNE, Australia - April 9, 2026 

Ecopha Biotech Pty Ltd today announced it is advancing an Australia–India strategy to support the global commercialisation of its proprietary ecopha.bio technology™, marking a significant step toward building a world-scale Pongamia-based bioeconomy platform.

The move reflects Ecopha’s transition from advanced research and development into international scale, as the company explores how Australian-developed biotechnology can be paired with India’s industrial capacity to enable large-scale production.

At the centre of the platform is a dual-output model that converts Pongamia oil, a non-food, low-carbon feedstock, into both sustainable aviation fuel (SAF) and marine-biodegradable PHA bioplastics.

A Scalable Model for Energy and Materials

The integrated system is designed to produce two high-demand outputs from a single feedstock:

• Sustainable Aviation Fuel (SAF), supporting aviation’s transition to lower-emissions energy
• PHA bioplastics, a next-generation material designed to biodegrade safely, including in natural environments

At full operational scale, a single facility is projected to process up to 1 million tonnes of Pongamia oil annually, with the potential to generate:

• 700,000 tonnes of SAF
• 200,000 tonnes of PHA bioplastics
• Approximately $3.2 billion in annual revenue

Exploring a Cross-Border Model

Ecopha is exploring a model that leverages the strengths of both regions:

• Australia as the technology and innovation hub for ecopha.bio technology™
• India as a potential large-scale production and feedstock hub

This approach is intended to create a vertically integrated platform spanning feedstock, technology, and manufacturing.

A Step Toward Global Deployment

“This collaboration is not just about production, it’s about building a new bioeconomy system,” said Dr Wilson Ling, CEO and Co-founder of Ecopha Biotech. “By uniting Australian innovation with Indian scale, we are creating a sovereign, scalable solution to the twin challenges of climate change and plastic pollution. This dual-output model shows that sustainability and high-margin profitability can go hand in hand.”

The initiative is designed to address two of the most pressing global challenges: decarbonising aviation and replacing conventional plastics with biodegradable alternatives.

 

About us:

About Ecopha Biotech Pty Ltd

Ecopha Biotech Pty Ltd is an Australian biotechnology company focused on commercialising PHA bioplastics and advanced biofuels through its ecopha.bio technology™ platform. The company integrates biotechnology, AI, and industrial systems to develop scalable, circular solutions for global markets.

Contact details:

Ecopha Biotech Media Relations

[email protected]

https://ecopha.bio